发明名称 |
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof |
摘要 |
The invention relates generally to activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that specifically binds to interleukin-6 receptor (IL-6R), and to methods of making and using these anti-IL-6R activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications. |
申请公布号 |
US9487590(B2) |
申请公布日期 |
2016.11.08 |
申请号 |
US201314036973 |
申请日期 |
2013.09.25 |
申请人 |
CYTOMX THERAPEUTICS, INC. |
发明人 |
West James William;Sagert Jason Gary;Hostetter Daniel Robert;Moore Stephen James;Nguyen Margaret Thy Luu;Vasiljeva Olga;Flandez Jeanne Grace |
分类号 |
A61K39/395;C07K16/28;A61K47/48;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Cooley LLP |
代理人 |
Cooley LLP ;Elrifi Ivor R. |
主权项 |
1. An activatable antibody that in an activated state binds Interleukin-6 Receptor (IL-6R) comprising:
an antibody or an antigen binding fragment thereof (AB) that specifically binds to the IL-6R, wherein the antibody comprises a heavy chain comprising an amino acid sequence comprising SEQ ID NO: 1 and a light chain comprising an amino acid sequence comprising SEQ ID NO: 2; a masking moiety (MM) that inhibits the binding of the AB to the IL-6R in an uncleaved state; and a cleavable moiety (CM) that is a polypeptide that functions as a substrate for a protease. |
地址 |
South San Francisco CA US |